E. Ma
Molecular Biology · Science · 2010–2019
A researcher in the Science corpus: 7 papers; trusts 1 researcher and is trusted by 5 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 131 citations into it; #6,972 of 17,773 by trust here, #1,649 by citations
Whom E. Ma trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts E. Ma overall
Papers from E. Ma's perspective
Ordered by how strongly the researchers E. Ma trusts endorse each paper. Same corpus, a different order for every researcher.
- CRISPR Provides Acquired Resistance Against Viruses in Prokaryotes (Science)
- Cas9–crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria (Proceedings of the National Academy of Sciences of the United States of America)
- CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III (Nature)
- Refinement of macromolecular structures by the maximum-likelihood method.
- Evolution and classification of the CRISPR-Cas systems (Nature Reviews Microbiology)
- Automated structure solution, density modification and model building.
- A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
- Cas9 as a versatile tool for engineering biology (Nature Methods)
- SPARX, a new environment for Cryo-EM image processing. (Journal of Structural Biology)
- An improved zinc-finger nuclease architecture for highly specific genome editing (Nature Biotechnology)
Their papers
- High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity (2013) — 1,433 citations
- RNA-programmed genome editing in human cells (2013) — 2,073 citations
- Structures of Cas9 Endonucleases Reveal RNA-Mediated Conformational Activation (2014) — 1,170 citations
- A Novel miRNA Processing Pathway Independent of Dicer Requires Argonaute2 Catalytic Activity (2010) — 901 citations
- CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity (2018) — 3,718 citations
- CRISPR-CasX is an RNA-dominated enzyme active for human genome editing (2019) — 360 citations
- Programmed DNA destruction by miniature CRISPR-Cas14 enzymes (2018) — 1,049 citations